X-LINKED ADRENOLEUKODYSTROPHY IN PATIENTS WITH IDIOPATHIC ADDISON-DISEASE

被引:17
作者
JORGE, P
QUELHAS, D
OLIVEIRA, P
PINTO, R
NOGUEIRA, A
机构
[1] INST GENET MED JACINTO MAGALHAES,UNIDADE ENZIMOL,P-4000 OPORTO,PORTUGAL
[2] UNIV MINHO,DEPT PROD & SISTEMAS,P-4700 BRAGA,PORTUGAL
关键词
ADDISON DISEASE; ADRENOMYELONEUROPATHY; PHENOTYPIC VARIABILITY; VERY LONG CHAIN FATTY ACIDS; X-LINKED ADRENOLEUKODYSTROPHY;
D O I
10.1007/BF02190668
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The two main causes of primary adrenal disease are tuberculosis and auto-immune adrenal destruction. The latter is responsible for about 70% of the cases of primary adrenal insufficiency (Addison disease). Commonly referred to as a rare cause of adrenal failure is X-linked adrenoleukodystrophy (ALD), a demyelinating peroxisomal disorder affecting 1: 20000 Caucasian males. Albeit primary adrenal insufficiency is a rare entity per se, we decided to study patients with idiopathic Addison disease and establish the frequency of ALD as a cause of adrenal insufficiency. The biochemical defect of ALD was found in 5 out of 24 patients. The small number of cases in our series led us to include in our analysis the published results of two other groups of investigators. This analysis indicates that the proportion of cases in which Addison disease is attributable to ALD is age dependent. It is highest when the adrenal insufficiency manifests before 15 years. This study clearly demonstrates that the proportion of ALD in patients presenting primary adrenal insufficiency has been underestimated.
引用
收藏
页码:594 / 597
页数:4
相关论文
共 18 条
  • [1] A 2-YEAR TRIAL OF OLEIC AND ERUCIC ACIDS (LORENZO OIL) AS TREATMENT FOR ADRENOMYELONEUROPATHY
    AUBOURG, P
    ADAMSBAUM, C
    LAVALLARDROUSSEAU, MC
    ROCCHICCIOLI, F
    CARTIER, N
    JAMBAQUE, I
    JAKOBEZAK, C
    LEMAITRE, A
    BOUREAU, F
    WOLF, C
    BOUGNERES, PF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (11) : 745 - 752
  • [2] BERRY DA, 1990, STATISTICS THEORY ME
  • [3] FOLCH J, 1957, J BIOL CHEM, V226, P497
  • [4] FOREST MG, 1989, CLIN PAEDIATRIC ENDO, P368
  • [5] HARDEN DG, 1960, BR J EXP PATHOL, V41, P31
  • [6] SCREENING OF PATIENTS WITH HEREDITARY SPASTIC PARAPARESIS AND ADDISONS-DISEASE FOR ADRENOLEUKODYSTROPHY ADRENOMYELONEUROPATHY
    HOLMBERG, BH
    HAGG, E
    DUCHEK, M
    HAGENFELDT, L
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 1992, 85 (02): : 147 - 149
  • [7] JAKOBS BS, 1991, BIOCHEM BIOPH RES CO, V21, P240
  • [8] CHARACTERIZATION OF X-LINKED ADRENOLEUKODYSTROPHY IN DIFFERENT BIOLOGICAL SPECIMENS FROM 10 PORTUGUESE FAMILIES
    JORGE, P
    QUELHAS, D
    NOGUEIRA, A
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 1993, 16 (01) : 55 - 62
  • [9] LORIAUX DL, 1990, PRINCIPLES PRACTICE, P600
  • [10] ADRENOLEUKODYSTROPHY - PHENOTYPIC VARIABILITY AND IMPLICATIONS FOR THERAPY
    MOSER, HW
    MOSER, AB
    SMITH, KD
    BERGIN, A
    BOREL, J
    SHANKROFF, J
    STINE, OC
    MERETTE, C
    OTT, J
    KRIVIT, W
    SHAPIRO, E
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 1992, 15 (04) : 645 - 664